RBD206-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
Author:
Funder
the National Natural Science Foundation of China
the National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics
Link
https://www.nature.com/articles/s41392-021-00798-8.pdf
Reference5 articles.
1. Cao, Y. et al. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. https://doi.org/10.1038/s41422-021-00514-9 (2021).
2. Chen, W.-H. et al. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum. Vaccin. Immunother. 10, 648–658 (2014).
3. Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. (80-.). 369, 330–333 (2020).
4. Dai, L. et al. A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 182, 722–733.e11 (2020).
5. Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205–1211 (2021).
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Click‐Type Enzymatic Method for Antigen‐Adjuvant Conjugation;Small Methods;2024-08-23
2. Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect;International Journal of Pharmaceutics;2024-03
3. Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses;Molecular Biomedicine;2023-10-19
4. Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions;Frontiers in Immunology;2023-10-05
5. Precise modification of the surface charge of antigen enhances vaccine immunogenicity;The Innovation;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3